|
Michelle Anderson, Senior Consultant, Life Sciences & Healthcare Regulatory Services, Deloitte & Touche LLP
Lynda Hilliard, Senior Manager, Life Science & Healthcare Regulatory Services, Deloitte & Touche LLP
- Understand the focus of the OIG on clinical research and incorporate high risk review areas into audit and monitoring plan
- List the core components of an ongoing and effective clinical research audit and monitoring plan
- Integrate clinical research audit and monitoring activities intoorganization-wide audit plan
|
|
|
|
